Document Detail


Do probiotics improve symptoms in patients with irritable bowel syndrome?
MedLine Citation:
PMID:  21180553     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
There is increasing evidence that inflammation or a disturbance of the flora within the gut might contribute to the pathogenesis of irritable bowel syndrome (IBS), at least in a proportion of cases. As a consequence it has been speculated that, as some probiotic bacteria have a range of anti-inflammatory and immunomodulatory properties, the administration of such organisms might prove to be beneficial in this condition. It has to be acknowledged that the quality and design of trials of probiotics in IBS has been somewhat variable but the majority have shown benefit, although some bacteria appear to be more effective than others. More recent studies using Bifidobacterium infantis 35624 and Bifidobacterium lactis DN-173-010 have given particularly encouraging results. Issues for the future include determining which organisms are most effective, defining optimal doses, comparing methods of delivery and assessing the role of mixtures or the addition of prebiotics.
Authors:
Peter J Whorwell
Related Documents :
21175733 - Learning to live with irritabel bowel syndrome. the influence of a group-based patient ...
7175553 - Horner's syndrome. criteria for oculosympathetic denervation.
22387593 - Decreased volume of the cerebral ventricles on ct images in gilles de la tourette's syn...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic advances in gastroenterology     Volume:  2     ISSN:  1756-2848     ISO Abbreviation:  Therap Adv Gastroenterol     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2010-12-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101478893     Medline TA:  Therap Adv Gastroenterol     Country:  England    
Other Details:
Languages:  eng     Pagination:  37-44     Citation Subset:  -    
Affiliation:
Education and Research Centre, Wythenshawe Hospital, Manchester, UK peter.whorwell@uhsm.nhs.uk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of probiotics on gastrointestinal function: evidence from animal models.
Next Document:  Endoluminal Treatment of Barrett's Esophagus: Current and Future Prospects.